Clinical Trial Update: Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates QRX-3 is being studied for prevention and treatment of chronic kidney disease progression in Phase 2 and Phase 3 trials, with th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Failure
• Kidney Injury

Drugs mentioned

• QRX-3

Snippet

Sponsor: Ebima Clifford Okundaye | Conditions: Chronic Kidney Diseases, Acute Kidney Injury | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING